stella
beta
A Dual-targeting Tracer TATE-RGD for the Diagnosis of SSTR- and RGD- Positive Tumors — Stella
Recruiting
Back to Iodine-resistant Thyroid Cancer trials
Early Phase 1 — Very small initial tests in humans, typically just a few people, to make sure the treatment is safe enough to study further.
Trial locations
(1 site)
China
Peking Union Medical College Hospital, Beijing, Beijing Municipality
View full record on ClinicalTrials.gov